Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Pediatr Res ; 38(2): 173-81, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7478812

ABSTRACT

A randomized, investigator-masked trial determined the effects of oral recombinant human transforming growth factor-alpha (TGF alpha) on jejunal mucosal recovery in 75 piglets with rotavirus diarrhea. Rotavirus inoculation of artificially reared piglets induced subtotal (approximately 50%) villus atrophy and watery diarrhea. Dietary TGF alpha was associated with significant restoration of villus surface area by 4 d postinoculation (p.i.) and complete restoration by 8 d p.i., whereas saline-treated animals required 12 d for recovery. Jejunal segments from clinically recovered TGF alpha-treated piglets showed an increase in electrical resistance across the epithelial barrier in vitro which was proportional to villus height. TGF alpha treatment for 12 d also produced a 30-50% increase in jejunal mucosal mass (protein content and wet weight), compared with the corresponding values in saline-treated piglets and in uninfected controls. However, oral TGF alpha did not hasten the resolution of diarrhea, enhance the specific activities of jejunal mucosal digestive enzymes, or increase jejunal glucose-stimulated Na+ absorption in vitro. We conclude that dietary TGF alpha stimulates jejunal mucosal hypertrophy, improves barrier function, and enhances regrowth of villi in rotavirus enteritis; however, it does not facilitate the restoration of functional activity or mucosal digestive enzymes. Oral TGF alpha can facilitate intestinal epithelial recovery in diseases associated with mucosal damage.


Subject(s)
Diarrhea, Infantile/drug therapy , Enteritis/drug therapy , Intestinal Mucosa/drug effects , Rotavirus Infections/drug therapy , Transforming Growth Factor alpha/pharmacology , Administration, Oral , Animals , Diarrhea, Infantile/pathology , Diarrhea, Infantile/virology , Disease Models, Animal , Electric Impedance , Enteritis/pathology , Enteritis/virology , Humans , Infant , Infant, Newborn , Intestinal Mucosa/pathology , Jejunum/drug effects , Jejunum/pathology , Random Allocation , Rotavirus Infections/pathology , Swine
2.
Am J Physiol ; 265(2 Pt 1): G388-93, 1993 Aug.
Article in English | MEDLINE | ID: mdl-8368320

ABSTRACT

To determine the mechanisms of K+ loss in viral diarrhea, K+ fluxes (estimated by tracer Rb+ flows) across piglet jejunum in Ussing chambers were determined. Normal jejunum was characterized by an indomethacin-sensitive short-circuit current and a small K+ secretory flow. Rotavirus-infected gut secreted K+ at high rates, probably resulting from increased prostaglandin generation because secretion was abolished by indomethacin. Tissues pretreated with indomethacin responded to 8-bromoadenosine 3',5'-cyclic monophosphate acid and 16,16-dimethyl-prostaglandin E2 with K+ secretion. The secretory response in rotavirus-infected jejunum was no greater than that in normal tissue. Serosal addition of Ca2+ ionophore A23187 caused K+ secretion in normal but not rotavirus-infected jejunum. To inhibit the basolateral uptake of K+ and reduce the driving force for secretion, ouabain was added to the bath. Ouabain unmasked a K+ absorptive process in normal intestine, which was not seen in rotavirus-infected tissue. K+ absorption was inhibited by 3-(cyanomethyl)-2-methyl-8-(phenyl-methoxy)imidazo (1,2 alpha)pyridine (Sch-28080) and omeprazole. We speculate that the high fecal K+ losses observed in human rotavirus enteritis might be caused by an imbalance between K+ secretion and an impaired apical K+ absorptive mechanism in the crypt-type epithelium.


Subject(s)
Enteritis/metabolism , Enteritis/microbiology , Jejunum/metabolism , Potassium/metabolism , Rotavirus Infections , Acute Disease , Animals , Animals, Newborn , Biological Transport , Indomethacin/pharmacology , Ouabain/pharmacology , Reference Values , Rubidium/metabolism , Swine
3.
Am J Physiol ; 263(6 Pt 1): G960-6, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1476202

ABSTRACT

To explore the relationship between intestinal fluid absorption and oxidative metabolism, we measured the effects of amino acids and glucose on piglet jejunal ion transport and oxygen consumption (QO2) in vitro. Jejunal QO2 was stimulated by L-glutamine and D-glucose but not by the nonmetabolizable organic solutes methyl beta-D-glucoside or L-phenylalanine. QO2 was maximally enhanced by the combination of D-glucose and L-glutamine (5 mM). Even though 5 mM L-glutamine was previously found to be insufficient to stimulate NaCl absorption, 5 mM L-glutamine enhanced jejunal NaCl flux when combined with equimolar mucosal D-glucose. Either D-glucose or methyl beta-D-glucoside caused an increase in short-circuit current (Isc), an increase in Na+ absorption in excess of Isc, and a decrease in Cl- secretion, when L-glutamine was substituted for D-glucose (10 mM) on the serosal side. This relationship suggests that mucosal sugars, if combined with L-glutamine, enhance neutral NaCl absorption as well as electrogenic Na+ flow. (Aminooxy)acetate, an inhibitor of alanine aminotransferase, abolished the stimulation of QO2 and the NaCl-absorptive response to L-glutamine. We conclude that the oxidative metabolism fueled by L-glutamine is linked to a NaCl-absorptive mechanism in the intestine. We propose that the CO2 produced by glutamine metabolism yields carbonic acid, which dissociates to H+ and HCO3-, which may stimulate parallel antiports in the apical membrane.


Subject(s)
Glucose/pharmacology , Glutamine/pharmacology , Sodium Chloride/pharmacokinetics , Absorption/drug effects , Animals , Animals, Newborn , Biological Transport/drug effects , Carbohydrates/pharmacology , Chlorides/pharmacokinetics , Glutamine/antagonists & inhibitors , Ions , Jejunum/metabolism , Oxidation-Reduction/drug effects , Oxygen Consumption/drug effects , Sodium/pharmacokinetics , Swine
4.
Gastroenterology ; 100(3): 811-7, 1991 Mar.
Article in English | MEDLINE | ID: mdl-1993505

ABSTRACT

Microvillus inclusion disease is an inherited intestinal brush border membrane defect that causes severe fluid and electrolyte malabsorption. In an infant with microvillus inclusion disease (confirmed by electron microscopic evaluation of rectal, jejunal, and gallbladder mucosae), basal stool output was massive (greater than 125 mL . kg-1 . day-1) and was not altered by treatment with clonidine or octreotide. A proximal jejunostomy with mucous fistula was placed, allowing separation of proximal from distal tract outputs (60 mL . kg-1 . day-1 and 100 mL . kg-1 . day-1, respectively). A 10-cm jejunal segment was excised during surgery and mounted in Ussing chambers for determination of transepithelial Na+ and Cl fluxes. Compared with intestine of normal infants, this infant's epithelium showed transmural conductance and unidirectional ion fluxes that were only 30% of normal. With respect to both Na+ and Cl, the excised jejunum was in a net secretory state. Theophylline (5 mmol/L) increased net Cl secretion slightly. In response to mucosal D-glucose (30 mmol/L), jejunal mucosal-to-serosal Na+ flux doubled. In the infant, glucose-electrolyte solution administered intrajejunally did not significantly change stool output, suggesting that all of the solution (40 mL/kg) was absorbed. Subtotal enterocolectomy, in theory, could have decreased purging by 66% in this infant with microvillus inclusion disease, but diarrhea would still have been significant.


Subject(s)
Chlorides/metabolism , Jejunum/surgery , Malabsorption Syndromes/metabolism , Microvilli/metabolism , Sodium/metabolism , Biological Transport, Active/physiology , Diarrhea/etiology , Diarrhea/physiopathology , Female , Humans , In Vitro Techniques , Infant, Newborn , Intestinal Absorption/physiology , Jejunostomy , Jejunum/pathology , Malabsorption Syndromes/pathology , Malabsorption Syndromes/surgery
5.
Gastroenterology ; 100(3): 683-91, 1991 Mar.
Article in English | MEDLINE | ID: mdl-1847119

ABSTRACT

Rotavirus enteritis is the leading cause of diarrhea in infants worldwide. A research priority of the World Health Organization is to develop oral rehydration solutions containing amino acids or other additives that will stimulate intestinal absorption more efficiently than the current glucose-based oral rehydration solutions. Glutamine is the principal metabolic fuel of the small bowel and a putative stimulator of mucosal repair. This report describes the transport response to mucosal L-glutamine following intestinal injury caused by porcine rotavirus. Peak symptoms and mucosal damage were observed 2-7 days after oral rotavirus inoculation. In vitro transport studies of the maximally injured region, the midjejunum (80% reduction in lactase), surprisingly, showed transport responses to L-glutamine (30 mmol/L) and L-alanine (30 mmol/L) that were similar qualitatively and quantitatively to those observed in control tissue. Subsequent application of mucosal D-glucose (30 mmol/L) caused additional stimulation of electrogenic Na+ transport, but the response to glucose was blunted (P less than 0.05) in the infected tissues. Glutamine and alanine enhanced Na+ absorption to a similar degree (2-2.5 muEq.cm-2.h-1), but glutamine stimulated equal amounts of electrogenic and electroneutral NaCl absorption, whereas alanine had no significant effect on net Cl- flux. Glutamine is a potentially useful substrate for investigation in oral rehydration solutions for infant diarrhea.


Subject(s)
Chlorides/metabolism , Glutamine/pharmacology , Intestinal Absorption/physiology , Intestinal Mucosa/metabolism , Jejunal Diseases/physiopathology , Jejunum/metabolism , Rotavirus Infections/physiopathology , Rotavirus , Sodium/metabolism , Alanine/pharmacology , Animals , Biological Transport, Active/drug effects , Enteritis/pathology , Enteritis/physiopathology , Ileum/metabolism , Intestinal Mucosa/pathology , Jejunal Diseases/pathology , Jejunum/pathology , Rotavirus Infections/pathology , Swine
6.
Am J Physiol ; 259(1 Pt 1): G99-107, 1990 Jul.
Article in English | MEDLINE | ID: mdl-2115304

ABSTRACT

Glutamine is the primary metabolic fuel of the small intestine. To determine the effects of glutamine on intestinal electrolyte transport, piglet (3 days to 3 wk old) jejunum was bathed in Ussing chambers in a buffer containing 10 mM serosal glucose, and the effects of different concentrations of mucosal L-glutamine and D-glucose on short-circuit current and transmucosal Na+ and Cl- transport were measured. Resting jejunum secreted Na+ and Cl- in an electrogenic manner. In contrast to mucosal D-glucose (30 mM), which promoted electrogenic Na+ absorption (1.8 mueq.cm-2.h-1), mucosal L-glutamine (30 mM) stimulated both Na+ (2.7 mueq.cm-2.h-1) and Cl- (2.2 mueq.cm-2.h-1) absorption. This NaCl-absorptive jejunal response depended on the presence of both Na+ and Cl-, did not appear until animals were greater than 7 days of age, and was not observed with glucose, phenylalanine, or mannitol. Serosal, as well as mucosal, glutamine (30 mM) promoted electroneutral NaCl absorption. A small electrogenic Na(+)-absorptive response to L-glutamine was also observed. The effect of L-glutamine on jejunal NaCl transport resembles that of other metabolic fuels on colonic transport; its mechanism remains to be determined. We conclude that glutamine promotes electroneutral salt absorption in the small intestine.


Subject(s)
Glutamine/pharmacology , Intestinal Absorption/drug effects , Jejunum/physiology , Sodium/metabolism , Aging , Animals , Animals, Newborn , Chlorides/metabolism , Electric Conductivity , Electrophysiology/methods , In Vitro Techniques , Intestinal Mucosa/physiology , Jejunum/drug effects , Jejunum/growth & development , Mannitol/pharmacology , Muscle Development , Muscle, Smooth/drug effects , Muscle, Smooth/growth & development , Muscle, Smooth/physiology , Phenylalanine/pharmacology , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...